Home>Topics>>Top Mid-Cap Biotech Stocks Being Accumulated By Legendary Fund Managers

Top Mid-Cap Biotech Stocks Being Accumulated By Legendary Fund Managers

Healthcare Sector and Stocks Analysis from Seeking Alpha

Mon, 23 Apr 2012

By Ganaxi Small Cap Movers : The biotech group as represented by the NYSE ARCA Biotech Index ($BTK) has been strong this year, now up over 31% YTD. With both the market and the biotech sector in strong bull mode, now maybe an opportune time to go 'shop' for biotech stocks. In this article, via an ...

Related Videos

  1. Biotech and Pharma Still Look Cheap

    Fri, 2 Sep 2011

    Dodge & Cox's Diana Strandberg and Charles Pohl discuss why the pharma industry looks like one of the most compelling places to invest today.

  2. Top Biotech Acquisition Candidates

    Thu, 5 Apr 2012

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

  3. A Sweet Spot in Mid-Caps

    Fri, 2 Sep 2011

    Legg Mason ClearBridge mid - cap managers Derek Deutsch and Brian Angerame on why mid-caps have outperformed over time and how valuations look today.

  4. How Artisan Beat the Pack in Down and Up Markets

    Fri, 4 Dec 2009

    Scott Satterwhite and Jim Kieffer on how Small Cap Value and Mid Cap Value held up significantly better than their rivals in the downturn and also managed to outperform in this year's rally.

Content Partners